Treatment News : Low Vitamin D Levels Associated With Serious HIV Disease Progression

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

May 2, 2011

Low Vitamin D Levels Associated With Serious HIV Disease Progression

HIV-positive people with very low vitamin D levels were more likely to develop AIDS and to die than people with higher vitamin D levels, according to a study published online January 25 in the journal AIDS.

Low vitamin D levels have been found in numerous studies in HIV-negative people to be associated with serious illnesses, including cardiovascular disease, cancer, diabetes and kidney failure. What’s more, a number of recent studies have found that the proportion of people with HIV who have low vitamin D levels is quite high, with fewer than a quarter in some studies having ideal levels.

There remains, however, some question about what blood level of vitamin D constitutes “deficiency.” Some studies have considered 30 nanograms per milliliter (ng/ml) of 25 hydroxy vitamin D in blood to be vitamin D deficient. Others have used 20 ng/ml. All studies, however, have considered levels below 10 ng/ml to be deficient.

Questions also remain regarding the actual health consequences of vitamin D deficiency in people living with HIV. Few studies have confirmed a link between low levels and illness or death.

To explore this link, Jean-Paul Viard, MD, from the Université Paris Descartes, Paris, and his colleagues examined vitamin D levels in the blood of 1,985 HIV-positive people enrolled in the EUROSIDA study. Viard’s team split the entire cohort of those with vitamin D samples into three groups: those with more than 30 ng/ml of vitamin D, those with between 10 and 30 ng/ml and those with less than 10 ng/ml.

As with other studies, very few people—just 11 percent—had ideal levels of vitamin D. Just over 65 percent had levels between 10 and 30 ng/ml, and nearly one quarter had extremely low vitamin D levels—less than 10 ng/ml.

Sunlight is a major source of vitamin D. Thus, Viard’s study found that blood samples taken during winter were far more likely than those taken in summer to have low vitamin D levels. Also, people who lived closer to the equator in Southern Europe were less likely to have low vitamin D levels.

Consistent with other studies, older participants and black participants were significantly more likely to have deficient vitamin D levels. Contrary to previous studies, however, people taking the antiretroviral drug efavirenz (found in Sustiva and Atripla) were no more likely to have low vitamin D levels.

Viard and his colleagues did find that low vitamin D levels were connected to illness and deaths. People with less than 10 ng/ml of vitamin D in blood were twice as likely to have AIDS as those with vitamin D levels over 30 ng/ml. They were also twice as likely to die from an AIDS-related cause and about 40 percent more likely to die of a non-AIDS-related cause.

It is this latter finding, about an increase in non-AIDS-related deaths, that Viard and his colleagues call out as significant. Non-AIDS deaths, particularly those associated with cardiovascular disease, are on the rise in people with HIV. Given the strength of the association between low vitamin D levels and cardiovascular disease in HIV-negative people, the team stated that “vitamin D deficiency therefore represents a new, independent, [unfavorable] prognostic marker in HIV infection.

“These results provide strong evidence that vitamin D deficiency is an important cofactor in HIV disease progression, even in the setting of widespread, efficient [ARV therapy],” the authors conclude. “Whether the relationship between vitamin D deficiency and events is causal must now be addressed, because of potential public health consequences.”

Search: Vitamin D, cardiovascular disease, non-AIDS, bone, Jean-Paul Viard, Paris, Rene Descarte, heart


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (3 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chipper52
    Palm Springs
    California


    zeze42
    Bay Area - Peninsula
    California


    ernienyc
    Bronx
    New York


    HOTROD2010
    houston
    Texas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?

Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.